|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 29, 2017 ) According to the report Middle East and Africa Radiotherapy Market, published by Market Data Forecast the Market was worth USD 490.5 million in 2016 and estimated to be growing at a CAGR of 5.8%, to reach USD 650.29 million by 2021.
Radiation therapy is considered as the key cancer treatment and for alternative type of treatment. Radiation therapy is also used to contract tumours and decrease pressure, pain, and other symptoms of cancer. This therapy may be healing in a number of different types of cancer if they are confined to one area of the body.
Browse market data tables and in-depth TOC of the Middle East and Africa Radiotherapy Industry to 2021 @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-radiotherapy-market-820/
Increasing number of cancer patients and fast varying cancer treatment technologies with recurrent invention are the key factors driving the market growth. Additionally, improvement of cancer treatment and inclination towards non-invasive procedures of treatment are augmenting the market growth. Absence of qualified workers to present radiotherapy and competent alternate treatment are the reasons obstructing the growth of the market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-radiotherapy-market-820/request-sample
The Middle-East and Africa radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Based on geography the market is analysed under various regions namely, Middle-East and Africa. Africa is leading the market in this region while Middle-East and estimated to witness highest growth rate in the coming years.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-radiotherapy-market-820/inquire
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
